Coverage
-
July 09, 2013
Earnouts are a nice idea, bridging the gap between what sellers think their company is worth and what buyers are willing to pay for unproven assets. But they often just swap upfront spats for infighting later on, as Thermo Fisher Scientific Inc. is finding out now.
1 other articles on this case.
View all »